Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 22Rectal Neoplasms 11Colonic Neoplasms 11Carcinoma, Hepatocellular 10Stomach Neoplasms 7Digestive System Neoplasms 3Neurotoxicity Syndromes 2Neoplasms 2Neoplasm Metastasis 2Intestinal Neoplasms 2Gastrointestinal Neoplasms 2Gastrointestinal Diseases 2Cholangiocarcinoma 2Recurrence 1Peripheral Nervous System Diseases 1Pancreatic Neoplasms 1Pancreatic Adenocarcinoma 1Ovarian Neoplasms 1Neoadjuvant Therapy 1Liver Neoplasms 1Intestinal Diseases 1Carcinoma, Ovarian Epithelial 1Carcinoma 1Advanced Colorectal Cancer 1

Interventions

pembrolizumab 1pamiparib 1abiraterone 1Prednisone 1Folfox protocol 1Fluorouracil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Neoadjuvant Therapy × Folfox protocol × Clear all
NCT05352165 2022-04-28

The Clinical Efficacy of Drug Sensitive Neoadjuvant Chemotherapy Based on Organoid Versus Traditional Neoadjuvant Chemotherapy in Advanced Rectal Cancer

Shanghai Minimally Invasive Surgery Center

Phase NA Unknown
192 enrolled

Neoadjuvant Therapy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡